Clinical observation of telmisartan and isosorbide mononltrate injection joint treatment on intensive pulmonary heart disease and heart failure
10.3760/cma.j.issn.1008-6706.2009.01.043
- VernacularTitle:替米沙坦联合单硝酸异山梨酯治疗肺心病心力衰竭疗效观察
- Author:
Xiaozhong MA
;
Chunze XIAO
- Publication Type:Journal Article
- Keywords:
Pulmonary heart disease;
Heart failure;
Telmisartan;
Isesorbide mononitrate injection
- From:
Chinese Journal of Primary Medicine and Pharmacy
2009;16(1):81-82
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of telmisartan and isosorbide mononitrate injection joint treat- ment on intensive pulmonary heart disease and heart failure. Methods 60 patients suffering from intensive pulmonary heart disease and heart failure were divided into observe group and control group randomly, patients in observe group were on the basis of the routine treatment given telmisartan and isosorbide mononitrate injection in 5 days period of treatment, while the control received only routine treatment, clinical effect of the two groups was observed and com-pared. Results Obvious effective rate was 74.3% and total effective rate was 92.7% which in control group were 46. 6% and 68. 3% ,respectively. There were significant difference in obvious effective rate and effective rates between the two groups(P <0.01). Conclusion The effect of telmisartan and isosorbide mononitrate injection joint treatment on intensive pulmonary heart disease and heart failure is excellent with less side-effects and safe medicament.
